Jim Cramer, a stalwart of stock market commentary, recently shifted gears on Bristol-Myers Squibb, pegging his hopes on their ...

Vicus Capital has trimmed its investment in Microsoft by 5.3%, selling 4,257 shares, yet the tech giant still secures a top ...

KLA Corporation saw a significant vote of confidence as UBS analyst Timothy Arcuri hiked the price target to a whopping $960, ...

Ever since Warren Buffett announced his exit plans, Berkshire Hathaway hasn't been keeping pace with the S&P 500. Investors ...

St. Louis Trust Co made waves this quarter by slashing its Amgen stakes by a startling 82.8%, leaving them with just 649 ...

Berkeley Capital Partners LLC amped up their stake in RTX Corporation by a whopping 48.6% in Q1. This aggressive buy pushed ...

Kestra Private Wealth Services increased its McDonald's holdings by 6.9% in Q1. They now hold 61,846 shares, valued at over ...

Bailard Inc. drastically reduced its stake in Regeneron Pharmaceuticals, offloading 69.9% of its shares in the first quarter.

Edgestream Partners L.P. took a significant step back from The Boeing Company, slashing its stake by a hefty 87.1%. After the ...

Morgan Stanley poached Aftab Shahsingh from UBS to spearhead industrial services coverage. Shahsingh brings over 15 years of ...

Leerink Partners has subtly lowered its FY2025 earnings prediction for Abbott Laboratories, now expecting a profit of $5.14 ...

Booking Holdings Inc. has been stamped with a "Moderate Buy" by analysts, signaling a potentially lucrative horizon for ...